A Prospective Randomised Comparative Clinical Trial Study of Luteal PhaseLetrozole versus Ganirelix Acetate Administration to Prevent Severity of Early Onset OHSS in ARTs.

Int J Fertil Steril · 2021 · PMC8530210 · PMID 34913294

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

As expected, letrozole has caused a more significant reduction in serum E2 levels in patients at high risk for OHSS in comparison to ganirelix acetate on day 7 post oocyte trigger, and a significant trend continued up to day 9.

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.